Invivogen: Ruxolitinib

Ruxolitinib
20-abx076799
  • EUR 1095.60
  • EUR 477.60
  • 25 mg
  • 5 mg

Human IgG antibody Laboratories manufactures the invivogen: ruxolitinib reagents distributed by Genprice. The Invivogen: Ruxolitinib reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Invivogen: products are available in stock. Specificity: Invivogen: Category: Ruxolitinib

Ruxolitinib phosphate
25 mg
EUR 268.8
Description: INCB018424 (Ruxolitinib) is an orally bioavailable JAK inhibitor .(IC50 values for JAK1, JAK2 and JAK3 are 3, 5 and 332 nM, respectively).INCB018424 is useful for rheumatoid arthritis.

Ruxolitinib phosphate
5 mg
EUR 157.2
Description: INCB018424 (Ruxolitinib) is an orally bioavailable JAK inhibitor .(IC50 values for JAK1, JAK2 and JAK3 are 3, 5 and 332 nM, respectively).INCB018424 is useful for rheumatoid arthritis.

Ruxolitinib phosphate
10 mM (in 1mL DMSO)
EUR 135.6
Description: INCB018424 (Ruxolitinib) is an orally bioavailable JAK inhibitor .(IC50 values for JAK1, JAK2 and JAK3 are 3, 5 and 332 nM, respectively).INCB018424 is useful for rheumatoid arthritis.

EZSolution? Ruxolitinib
each
EUR 261.6

INCB018424 (Ruxolitinib)
5mg
EUR 625.2

Ruxolitinib (phosphate)
5mg
EUR 142.8

Ruxolitinib (sulfate)
100mg
EUR 622.8

Chemicals information

Ruxolitinib . phosphate salt
10-043 25 mg
EUR 387.96
Description: Water-soluble phosphate salt of Ruxolitinib. Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19)

Ruxolitinib (JAK kinase inhibitor)
SIH-509-25MG 25 mg
EUR 750
Description: The substance Ruxolitinib is a jak kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml).

Ruxolitinib (JAK kinase inhibitor)
SIH-509-5MG 5 mg
EUR 285.6
Description: The substance Ruxolitinib is a jak kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml).

GFP-lacZ (His) Lentiviral particles, invivo ready
LVP021-PBS 5x107 IFU/ml x 200ul
EUR 1034.4
Description: Pre-made lentiviral particles expressing GFP-LacZ fusion gene with C-term His tag. A RFP was bicistronically expressed under the same suCMV promoter. Concentrated Particles are provided in PBS solution.

S-Ruxolitinib (INCB018424)
A4149-1 1 mg
EUR 277.2
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway.

S-Ruxolitinib (INCB018424)
A4149-5 5 mg
EUR 514.8
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway.

S-Ruxolitinib (INCB018424)
A4149-5.1 10 mM (in 1mL DMSO)
EUR 367.2
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway.

Recombinant Mouse TECTB Protein, His, Invitro-E.coli-10ug
QP9985-iv-10ug 10ug
EUR 936

Recombinant Mouse TECTB Protein, His, Invitro-E.coli-50ug
QP9985-iv-50ug 50ug
EUR 554.4

ODN 2041-Non-CpG ODN. Invitro control for rabbit cells. Antigen grade
ODN2041-1 1 mg
EUR 781.2

Recombinant Mouse TECTB Protein, His, Invitro-E.coli-100ug
QP9985-iv-100ug 100ug
EUR 1424.4

Recombinant Human PSAP A1 Protein, His-B2M, Invitro-E.coli-10ug
QP10005-iv-10ug 10ug
EUR 554.4

Recombinant Human PSAP A1 Protein, His-B2M, Invitro-E.coli-50ug
QP10005-iv-50ug 50ug
EUR 936

Recombinant Human PSAP A2 Protein, His-B2M, Invitro-E.coli-10ug
QP10008-iv-10ug 10ug
EUR 554.4

Recombinant Human PSAP A2 Protein, His-B2M, Invitro-E.coli-50ug
QP10008-iv-50ug 50ug
EUR 936

Recombinant Human CD19/ Leu-12 Protein, His, Invitro-E.coli-10ug
QP5782-iv-10ug 10ug
EUR 979.2

Recombinant Human CD19/ Leu-12 Protein, His, Invitro-E.coli-50ug
QP5782-iv-50ug 50ug
EUR 619.2